Remove Manufacturing Remove Networking Remove Training
article thumbnail

University of Oklahoma to open bioprocessing training facility

European Pharmaceutical Review

Gallogly College of Engineering at The University of Oklahoma (OU) has announced it will open the OU Bioprocessing Core Facility, a shared research centre for biopharmaceutical manufacturing and bioprocess engineering in 2023. The EDA will also finance five more Oklahoma-based projects: Biomanufacturing Workforce Training Center.

article thumbnail

Manufacturing Sales Training: Key Strategies For Success

Spotio

Sales reps in the manufacturing industry face unique challenges. But you need to train your reps to overcome the challenges in front of them and close deals. A strong manufacturing sales training program can help. What Is Manufacturing Sales Training? Why Is Manufacturing Sales Training Important?

article thumbnail

Guaranteeing resilience in vaccine manufacturing

European Pharmaceutical Review

There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.

article thumbnail

EMA launches quality control group to aid medicine innovation

European Pharmaceutical Review

The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU).

Medicine 111
article thumbnail

Championing UK ATMP clinical trials

European Pharmaceutical Review

Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. The funding will start with three established Centres, and then across an expanded network, according to Chief Clinical Officer for Cell and Gene Therapy Catapult, Jacqueline Barry.

article thumbnail

New UK drug delivery centre to support RNA therapeutic development

European Pharmaceutical Review

Under the first-of-its-kind partnership in the UK, CPI will work with the Medicines Discovery Catapult, the University of Strathclyde, the University of Liverpool and Imperial College London using a £10 million, three-year grant funded by Innovate UK’s Transforming Medicines Manufacturing programme.

article thumbnail

Collaborations between pharma and academia increase

European Pharmaceutical Review

Moreover, 70 percent of undergraduate placements fell within R&D and manufacturing. The benefits of exposing students to the industry this way enables both parties to share knowledge, experience and provides students networking opportunities that can be difficult to obtain for such a competitive industry, said ABPI.

Pharma 104